Tissue markers may predict treatment response to antitumor necrosis factor‐α agents in children with Crohn's disease

Ähnliche Einträge

• Long‐term laboratory follow‐up is essential in pediatric patients with celiac
  von: Alexander Krauthammer, et al.
  Veröffentlicht: (2025)
• Crohn's disease exclusion diet as an add‐on to antitumor necrosis factor‐α therapy in children with moderate‐to‐severe Crohn's disease
  von: Saverio Pochesci, et al.
  Veröffentlicht: (2025)
• Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease
  von: Tal Marshanski, et al.
  Veröffentlicht: (2024)
• Maintenance‐phase serum anti‐TNF levels are not associated with mucosal healing in pediatric Crohn's disease
  von: Rinat Grabovski, et al.
  Veröffentlicht: (2025)
• Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review
  von: Ohad Atia, et al.
  Veröffentlicht: (2025)